ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Rejection"

  • 2021 American Transplant Congress

    Donor-Derived Cell-Free DNA Can Differentiate Rejection versus Other Causes of Pancreas Transplant Dysfunction

    N. Ali1, J. Miles2, Z. Stewart Lewis1

    1Transplant Institute, NYU Langone Health, New York, NY, 2CareDx, Brisbane, CA

    *Purpose: Assessment and early detection of allograft injury in simultaneous pancreas and kidney (SPK) transplant recipients has clear benefits for optimizing treatment and intervention. Donor-derived…
  • 2021 American Transplant Congress

    A Single Nucleotide Polymorphism within the FCGR3A 158 F/V Gene is Associated with Decreased Survival of Renal Allografts with Chronic Active Antibody-Mediated Rejection

    N. H. Litjens, A. M. Peeters, J. A. Kal-van Gestel, M. Klepper, M. G. Betjes

    Internal Medicine, Nephrology and Transplantation, Erasmus MC, University Medical Center, Rotterdam, Netherlands

    *Purpose: Long-term allograft survival has shown little improvement over the last decades. An important factor compromising long-term allograft survival in kidney transplantation is chronic active…
  • 2021 American Transplant Congress

    Effects of Timing of Everolimus Transition on Renal Outcomes in Liver Transplant Recipients

    M. Leick1, H. Belleau2, T. McCashland3

    1Nebraska Medicine, Omaha, NE, 2Bryan Health, Lincoln, NE, 3University of Nebraska Medical Center, Omaha, NE

    *Purpose: The purpose of this study is to evaluate the effects of the timing of everolimus transition on renal outcomes in liver transplant recipients.*Methods: This…
  • 2021 American Transplant Congress

    Kidney Transplant Rejection Can Be Diagnosed or Even Predicted by Tracking Donor Reactive T Cell Clones in Post-transplant Samples

    Y. Sambandam1, M. Kandpal1, J. He1, X. Huang1, T. S. Taylor1, A. A. Shetty2, J. M. Mathew1, J. R. Leventhal1

    1Surgery-Comprehensive Transplant Center, Northwestern University Feinberg School of Medicine, Chicago, IL, 2Medicine, Nephrology Division, Northwestern University Feinberg School of Medicine, Chicago, IL

    *Purpose: To test if kidney transplant (KTx) rejection can be diagnosed by monitoring for donor reactive T-cell (DRTC) clones in post-transplant (post-tx) biopsy and non-invasively…
  • 2021 American Transplant Congress

    Low Socio-economic Status is Associated with Lower Kidney Graft Survival and Increased Risk of Graft Failure Due to Acute Rejection

    W. Xie1, G. Vrakas1, S. H. Gray1, A. Haririan2, J. R. Scalea1, J. S. Bromberg1, D. G. Maluf1, R. P. Meier1

    1Department of Surgery, University of Maryland School of Medicine, Baltimore, MD, 2Department of Medicine, University of Maryland School of Medicine, Baltimore, MD

    *Purpose: Low socio-economic status (SES) has been shown to be associated with poor kidney graft outcomes. We aimed to characterize differences in high and low…
  • 2021 American Transplant Congress

    Is There a Role for Donor-Specific Antibody Testing in Simultaneous Liver-Kidney Transplantation? A Single Center Analysis of Outcomes

    A. Das, A. Barbetta, D. Remulla, C. Goldbeck, T. Maw, J. Kim

    University of Southern California, Los Angeles, CA

    *Purpose: Simultaneous liver-kidney transplantation (SLKT) has grown exponentially since its conception in the 1960’s. The role for donor specific antibody (DSA) testing in SLKT is…
  • 2021 American Transplant Congress

    Anti-HLA-DP Antibodies Positive – A Retrospective Review of Outcomes in Renal Transplantation- Single Centre Experience

    O. Piscoran1, J. Worthington2, R. Dhillon1, T. Augustine1, M. Picton1, M. Morton1, S. Bhutani1

    1Urology, Renal and Transplantation, Manchester University NHS Foundation Trust, Manchester, United Kingdom, 2Transplantation Laboratory, Manchester University NHS Foundation Trust, Manchester, United Kingdom

    *Purpose: Data on the role of HLA-DP antibodies on graft outcome is not precise. Studies suggested that the presence of donor-directed HLA-DP antibodies correlate with…
  • 2021 American Transplant Congress

    Comparison of Next Generation Sequencing Donor-derived Cell Free DNA Assay Utilizing Whole Genome Sequencing

    N. Singh1, M. S. Naseer1, D. Aultman2, H. Shokouh-Amiri2, G. Zibari2

    1Transplant, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA, 2Advanced Surgery, John C. McDonald Regional Transplant Center - Willis Knighton Health System, Shreveport, LA

    *Purpose: Circulating donor-derived cell free DNA (dd-cfDNA) is a non-invasive biomarker of kidney allograft injury with a high negative predictive value for ruling out acute…
  • 2021 American Transplant Congress

    Impact of Treatment of Subclinical Rejection at 2 Weeks After Kidney Transplantation, Compared by 1 Year Histologic Outcomes

    O. Lee1, K. Lee1, J. Park1, J. Lee2, G. Kwon3, K. Kim4

    1Surgery, Samsung Medical Center, Seoul, Korea, Republic of, 2Medicine, Samsung Medical Center, Seoul, Korea, Republic of, 3Pathology, Samsung Medical Center, Seoul, Korea, Republic of, 4Biostatistics, Samsung Medical Center, Seoul, Korea, Republic of

    *Purpose: Subclinical rejection (SCR) is associated with chronic allograft nephropathy, which is the most common cause of allograft failure in kidney transplantation (KT). Therefore, early…
  • 2021 American Transplant Congress

    Utility of Donor-Derived Cell Free DNA for Detecting ABMR in Patients With AT1R Antibodies

    S. Kant1, D. Kumar2, I. Moinuddin2, T. Alhamad3, M. Haris3, J. Gray4, B. Dale4, M. Bettinotti1, D. C. Brennan1

    1Johns Hopkins University School of Medicine, Baltimore, MD, 2VCU, Richmond, VA, 3Wash Univ, St. Louis, MO, 4CareDx, Brisbane, CA

    *Purpose: The presence of angiotensin II type 1 receptor (AT1R) antibodies is associated with non-HLA active antibody mediated rejection (ABMR). The frequent co-existence of negative…
  • « Previous Page
  • 1
  • …
  • 35
  • 36
  • 37
  • 38
  • 39
  • …
  • 172
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences